LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK, Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results